Global Narcotic Analgesics Market

Narcotic Analgesics Comprehensive Study by Type (Oxycodone, Fentanyl, Hydrocodone, Hydromorphone, Morphine, Methadone, Oxymorphone, Pentazocine), Form (Natural, Semi-Synthetic, Synthetic), Distribution Channel (Hospital, Medical Center, Retail Pharmacies, Drug Stores), Dosage (Tablets and Capsule, Patches, Injections, Oral Liquids, Others (Films, Sprays)) Players and Region - Global Market Outlook to 2030

Narcotic Analgesics Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Narcotic Analgesics Market Scope
Narcotic Analgesics is a pain reliever, which is made from codeine or synthetic codeine or aspirin to offer more effective pain relief. The major brand names are Percocet, oxycodone, OxyContin, Tylenol with codeine, Tylox, and Lortab. These medicines are used for a short duration of time for relief from acute pain. These drugs are utilized for various types of arthritis. These drugs are having some side effects by causing the user to become drowsy, dizzy, or lightheaded.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledSanofi S.A. (France), Novartis AG (Switzerland), GlaxoSmithKline PLC (United Kingdom), Pfizer (United States), Reckitt Benckiser (United Kingdom), Endo Pharmaceuticals (United Kingdom), Mallinckrodt Pharmaceuticals (United Kingdom) and Endo Pharmaceuticals Inc. (Ireland)
CAGR%


The global Narcotic Analgesics market is highly competitive and consists of some key players. In concern with the market share, some of the key players presently dominate the global market. These market players are leveraging on strategic collaborative creativities to intensification their market share and escalation their profitability. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Narcotic Analgesics market throughout the predicted period.

Sanofi S.A. (France), Novartis AG (Switzerland), GlaxoSmithKline PLC (United Kingdom), Pfizer (United States), Reckitt Benckiser (United Kingdom), Endo Pharmaceuticals (United Kingdom), Mallinckrodt Pharmaceuticals (United Kingdom) and Endo Pharmaceuticals Inc. (Ireland) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Sun Pharmaceutical Industries Ltd. (India) and Egalet (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Narcotic Analgesics market by Type and Region with country level break-up.

On the basis of geography, the market of Narcotic Analgesics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2023.

Market Leaders and their expansionary development strategies
In October, 2019 Companies in the analgesics market are increasingly focusing on acquisition as a strategy for growth. Leading analgesic drug manufacturers are acquiring smaller companies to gain competitive advantage and strengthen their market position.
In March, 2023 Sanofi and Provention Bio, Inc., a U.S.-based, publicly traded biopharmaceutical company focused on intercepting and preventing immune-mediated diseases including type 1 diabetes (T1D), have entered into an agreement under which Sanofi has agreed to acquire Provention Bio, Inc., for USD 25.00 per share in cash, representing an equity value of approximately USD2.9 billion.


Influencing Trend:
Advancement in Research and Development Innovative and Increase Number of Manufacturing Units across the Asia Pacific Regions

Market Growth Drivers:
High Growth of Tolerance for Non-Narcotic Analgesics, High Demand for High Pain Management and Increasing Number Chronic Pain Associated With Cancer and Arthritis Conditions

Challenges:
High Manufacturing Cost

Restraints:
Stringent Government Regulations

Opportunities:
High Growth in the Healthcare Industry and Increasing Number of Government Initiatives In Terms Of Distribution Channels

Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Narcotic Analgesics Manufacturers, Suppliers and Distributors, Raw Material Suppliers, Government Regulatory and Research Organizations and End-Use Industries

Report Objectives / Segmentation Covered

By Type
  • Oxycodone
  • Fentanyl
  • Hydrocodone
  • Hydromorphone
  • Morphine
  • Methadone
  • Oxymorphone
  • Pentazocine
By Form
  • Natural
  • Semi-Synthetic
  • Synthetic

By Distribution Channel
  • Hospital
  • Medical Center
  • Retail Pharmacies
  • Drug Stores

By Dosage
  • Tablets and Capsule
  • Patches
  • Injections
  • Oral Liquids
  • Others (Films, Sprays)

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. High Growth of Tolerance for Non-Narcotic Analgesics
      • 3.2.2. High Demand for High Pain Management
      • 3.2.3. Increasing Number Chronic Pain Associated With Cancer and Arthritis Conditions
    • 3.3. Market Challenges
      • 3.3.1. High Manufacturing Cost
    • 3.4. Market Trends
      • 3.4.1. Advancement in Research and Development Innovative
      • 3.4.2. Increase Number of Manufacturing Units across the Asia Pacific Regions
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Narcotic Analgesics, by Type, Form, Distribution Channel, Dosage and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Narcotic Analgesics (Value)
      • 5.2.1. Global Narcotic Analgesics by: Type (Value)
        • 5.2.1.1. Oxycodone
        • 5.2.1.2. Fentanyl
        • 5.2.1.3. Hydrocodone
        • 5.2.1.4. Hydromorphone
        • 5.2.1.5. Morphine
        • 5.2.1.6. Methadone
        • 5.2.1.7. Oxymorphone
        • 5.2.1.8. Pentazocine
      • 5.2.2. Global Narcotic Analgesics by: Form (Value)
        • 5.2.2.1. Natural
        • 5.2.2.2. Semi-Synthetic
        • 5.2.2.3. Synthetic
      • 5.2.3. Global Narcotic Analgesics by: Distribution Channel (Value)
        • 5.2.3.1. Hospital
        • 5.2.3.2. Medical Center
        • 5.2.3.3. Retail Pharmacies
        • 5.2.3.4. Drug Stores
      • 5.2.4. Global Narcotic Analgesics by: Dosage (Value)
        • 5.2.4.1. Tablets and Capsule
        • 5.2.4.2. Patches
        • 5.2.4.3. Injections
        • 5.2.4.4. Oral Liquids
        • 5.2.4.5. Others (Films, Sprays)
      • 5.2.5. Global Narcotic Analgesics Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Narcotic Analgesics (Volume)
      • 5.3.1. Global Narcotic Analgesics by: Type (Volume)
        • 5.3.1.1. Oxycodone
        • 5.3.1.2. Fentanyl
        • 5.3.1.3. Hydrocodone
        • 5.3.1.4. Hydromorphone
        • 5.3.1.5. Morphine
        • 5.3.1.6. Methadone
        • 5.3.1.7. Oxymorphone
        • 5.3.1.8. Pentazocine
      • 5.3.2. Global Narcotic Analgesics by: Form (Volume)
        • 5.3.2.1. Natural
        • 5.3.2.2. Semi-Synthetic
        • 5.3.2.3. Synthetic
      • 5.3.3. Global Narcotic Analgesics by: Distribution Channel (Volume)
        • 5.3.3.1. Hospital
        • 5.3.3.2. Medical Center
        • 5.3.3.3. Retail Pharmacies
        • 5.3.3.4. Drug Stores
      • 5.3.4. Global Narcotic Analgesics by: Dosage (Volume)
        • 5.3.4.1. Tablets and Capsule
        • 5.3.4.2. Patches
        • 5.3.4.3. Injections
        • 5.3.4.4. Oral Liquids
        • 5.3.4.5. Others (Films, Sprays)
      • 5.3.5. Global Narcotic Analgesics Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Narcotic Analgesics (Price)
      • 5.4.1. Global Narcotic Analgesics by: Type (Price)
  • 6. Narcotic Analgesics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Sanofi S.A. (France)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Novartis AG (Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. GlaxoSmithKline PLC (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Pfizer (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Reckitt Benckiser (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Endo Pharmaceuticals (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Mallinckrodt Pharmaceuticals (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Endo Pharmaceuticals Inc. (Ireland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Narcotic Analgesics Sale, by Type, Form, Distribution Channel, Dosage and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Narcotic Analgesics (Value)
      • 7.2.1. Global Narcotic Analgesics by: Type (Value)
        • 7.2.1.1. Oxycodone
        • 7.2.1.2. Fentanyl
        • 7.2.1.3. Hydrocodone
        • 7.2.1.4. Hydromorphone
        • 7.2.1.5. Morphine
        • 7.2.1.6. Methadone
        • 7.2.1.7. Oxymorphone
        • 7.2.1.8. Pentazocine
      • 7.2.2. Global Narcotic Analgesics by: Form (Value)
        • 7.2.2.1. Natural
        • 7.2.2.2. Semi-Synthetic
        • 7.2.2.3. Synthetic
      • 7.2.3. Global Narcotic Analgesics by: Distribution Channel (Value)
        • 7.2.3.1. Hospital
        • 7.2.3.2. Medical Center
        • 7.2.3.3. Retail Pharmacies
        • 7.2.3.4. Drug Stores
      • 7.2.4. Global Narcotic Analgesics by: Dosage (Value)
        • 7.2.4.1. Tablets and Capsule
        • 7.2.4.2. Patches
        • 7.2.4.3. Injections
        • 7.2.4.4. Oral Liquids
        • 7.2.4.5. Others (Films, Sprays)
      • 7.2.5. Global Narcotic Analgesics Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Narcotic Analgesics (Volume)
      • 7.3.1. Global Narcotic Analgesics by: Type (Volume)
        • 7.3.1.1. Oxycodone
        • 7.3.1.2. Fentanyl
        • 7.3.1.3. Hydrocodone
        • 7.3.1.4. Hydromorphone
        • 7.3.1.5. Morphine
        • 7.3.1.6. Methadone
        • 7.3.1.7. Oxymorphone
        • 7.3.1.8. Pentazocine
      • 7.3.2. Global Narcotic Analgesics by: Form (Volume)
        • 7.3.2.1. Natural
        • 7.3.2.2. Semi-Synthetic
        • 7.3.2.3. Synthetic
      • 7.3.3. Global Narcotic Analgesics by: Distribution Channel (Volume)
        • 7.3.3.1. Hospital
        • 7.3.3.2. Medical Center
        • 7.3.3.3. Retail Pharmacies
        • 7.3.3.4. Drug Stores
      • 7.3.4. Global Narcotic Analgesics by: Dosage (Volume)
        • 7.3.4.1. Tablets and Capsule
        • 7.3.4.2. Patches
        • 7.3.4.3. Injections
        • 7.3.4.4. Oral Liquids
        • 7.3.4.5. Others (Films, Sprays)
      • 7.3.5. Global Narcotic Analgesics Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Narcotic Analgesics (Price)
      • 7.4.1. Global Narcotic Analgesics by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Narcotic Analgesics: by Type(USD Million)
  • Table 2. Narcotic Analgesics Oxycodone , by Region USD Million (2018-2023)
  • Table 3. Narcotic Analgesics Fentanyl , by Region USD Million (2018-2023)
  • Table 4. Narcotic Analgesics Hydrocodone , by Region USD Million (2018-2023)
  • Table 5. Narcotic Analgesics Hydromorphone , by Region USD Million (2018-2023)
  • Table 6. Narcotic Analgesics Morphine , by Region USD Million (2018-2023)
  • Table 7. Narcotic Analgesics Methadone , by Region USD Million (2018-2023)
  • Table 8. Narcotic Analgesics Oxymorphone , by Region USD Million (2018-2023)
  • Table 9. Narcotic Analgesics Pentazocine , by Region USD Million (2018-2023)
  • Table 10. Narcotic Analgesics: by Form(USD Million)
  • Table 11. Narcotic Analgesics Natural , by Region USD Million (2018-2023)
  • Table 12. Narcotic Analgesics Semi-Synthetic , by Region USD Million (2018-2023)
  • Table 13. Narcotic Analgesics Synthetic , by Region USD Million (2018-2023)
  • Table 14. Narcotic Analgesics: by Distribution Channel(USD Million)
  • Table 15. Narcotic Analgesics Hospital , by Region USD Million (2018-2023)
  • Table 16. Narcotic Analgesics Medical Center , by Region USD Million (2018-2023)
  • Table 17. Narcotic Analgesics Retail Pharmacies , by Region USD Million (2018-2023)
  • Table 18. Narcotic Analgesics Drug Stores , by Region USD Million (2018-2023)
  • Table 19. Narcotic Analgesics: by Dosage(USD Million)
  • Table 20. Narcotic Analgesics Tablets and Capsule , by Region USD Million (2018-2023)
  • Table 21. Narcotic Analgesics Patches , by Region USD Million (2018-2023)
  • Table 22. Narcotic Analgesics Injections , by Region USD Million (2018-2023)
  • Table 23. Narcotic Analgesics Oral Liquids , by Region USD Million (2018-2023)
  • Table 24. Narcotic Analgesics Others (Films, Sprays) , by Region USD Million (2018-2023)
  • Table 25. South America Narcotic Analgesics, by Country USD Million (2018-2023)
  • Table 26. South America Narcotic Analgesics, by Type USD Million (2018-2023)
  • Table 27. South America Narcotic Analgesics, by Form USD Million (2018-2023)
  • Table 28. South America Narcotic Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 29. South America Narcotic Analgesics, by Dosage USD Million (2018-2023)
  • Table 30. Brazil Narcotic Analgesics, by Type USD Million (2018-2023)
  • Table 31. Brazil Narcotic Analgesics, by Form USD Million (2018-2023)
  • Table 32. Brazil Narcotic Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 33. Brazil Narcotic Analgesics, by Dosage USD Million (2018-2023)
  • Table 34. Argentina Narcotic Analgesics, by Type USD Million (2018-2023)
  • Table 35. Argentina Narcotic Analgesics, by Form USD Million (2018-2023)
  • Table 36. Argentina Narcotic Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 37. Argentina Narcotic Analgesics, by Dosage USD Million (2018-2023)
  • Table 38. Rest of South America Narcotic Analgesics, by Type USD Million (2018-2023)
  • Table 39. Rest of South America Narcotic Analgesics, by Form USD Million (2018-2023)
  • Table 40. Rest of South America Narcotic Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 41. Rest of South America Narcotic Analgesics, by Dosage USD Million (2018-2023)
  • Table 42. Asia Pacific Narcotic Analgesics, by Country USD Million (2018-2023)
  • Table 43. Asia Pacific Narcotic Analgesics, by Type USD Million (2018-2023)
  • Table 44. Asia Pacific Narcotic Analgesics, by Form USD Million (2018-2023)
  • Table 45. Asia Pacific Narcotic Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 46. Asia Pacific Narcotic Analgesics, by Dosage USD Million (2018-2023)
  • Table 47. China Narcotic Analgesics, by Type USD Million (2018-2023)
  • Table 48. China Narcotic Analgesics, by Form USD Million (2018-2023)
  • Table 49. China Narcotic Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 50. China Narcotic Analgesics, by Dosage USD Million (2018-2023)
  • Table 51. Japan Narcotic Analgesics, by Type USD Million (2018-2023)
  • Table 52. Japan Narcotic Analgesics, by Form USD Million (2018-2023)
  • Table 53. Japan Narcotic Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 54. Japan Narcotic Analgesics, by Dosage USD Million (2018-2023)
  • Table 55. India Narcotic Analgesics, by Type USD Million (2018-2023)
  • Table 56. India Narcotic Analgesics, by Form USD Million (2018-2023)
  • Table 57. India Narcotic Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 58. India Narcotic Analgesics, by Dosage USD Million (2018-2023)
  • Table 59. South Korea Narcotic Analgesics, by Type USD Million (2018-2023)
  • Table 60. South Korea Narcotic Analgesics, by Form USD Million (2018-2023)
  • Table 61. South Korea Narcotic Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 62. South Korea Narcotic Analgesics, by Dosage USD Million (2018-2023)
  • Table 63. Taiwan Narcotic Analgesics, by Type USD Million (2018-2023)
  • Table 64. Taiwan Narcotic Analgesics, by Form USD Million (2018-2023)
  • Table 65. Taiwan Narcotic Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 66. Taiwan Narcotic Analgesics, by Dosage USD Million (2018-2023)
  • Table 67. Australia Narcotic Analgesics, by Type USD Million (2018-2023)
  • Table 68. Australia Narcotic Analgesics, by Form USD Million (2018-2023)
  • Table 69. Australia Narcotic Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 70. Australia Narcotic Analgesics, by Dosage USD Million (2018-2023)
  • Table 71. Rest of Asia-Pacific Narcotic Analgesics, by Type USD Million (2018-2023)
  • Table 72. Rest of Asia-Pacific Narcotic Analgesics, by Form USD Million (2018-2023)
  • Table 73. Rest of Asia-Pacific Narcotic Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 74. Rest of Asia-Pacific Narcotic Analgesics, by Dosage USD Million (2018-2023)
  • Table 75. Europe Narcotic Analgesics, by Country USD Million (2018-2023)
  • Table 76. Europe Narcotic Analgesics, by Type USD Million (2018-2023)
  • Table 77. Europe Narcotic Analgesics, by Form USD Million (2018-2023)
  • Table 78. Europe Narcotic Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 79. Europe Narcotic Analgesics, by Dosage USD Million (2018-2023)
  • Table 80. Germany Narcotic Analgesics, by Type USD Million (2018-2023)
  • Table 81. Germany Narcotic Analgesics, by Form USD Million (2018-2023)
  • Table 82. Germany Narcotic Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 83. Germany Narcotic Analgesics, by Dosage USD Million (2018-2023)
  • Table 84. France Narcotic Analgesics, by Type USD Million (2018-2023)
  • Table 85. France Narcotic Analgesics, by Form USD Million (2018-2023)
  • Table 86. France Narcotic Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 87. France Narcotic Analgesics, by Dosage USD Million (2018-2023)
  • Table 88. Italy Narcotic Analgesics, by Type USD Million (2018-2023)
  • Table 89. Italy Narcotic Analgesics, by Form USD Million (2018-2023)
  • Table 90. Italy Narcotic Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 91. Italy Narcotic Analgesics, by Dosage USD Million (2018-2023)
  • Table 92. United Kingdom Narcotic Analgesics, by Type USD Million (2018-2023)
  • Table 93. United Kingdom Narcotic Analgesics, by Form USD Million (2018-2023)
  • Table 94. United Kingdom Narcotic Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 95. United Kingdom Narcotic Analgesics, by Dosage USD Million (2018-2023)
  • Table 96. Netherlands Narcotic Analgesics, by Type USD Million (2018-2023)
  • Table 97. Netherlands Narcotic Analgesics, by Form USD Million (2018-2023)
  • Table 98. Netherlands Narcotic Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 99. Netherlands Narcotic Analgesics, by Dosage USD Million (2018-2023)
  • Table 100. Rest of Europe Narcotic Analgesics, by Type USD Million (2018-2023)
  • Table 101. Rest of Europe Narcotic Analgesics, by Form USD Million (2018-2023)
  • Table 102. Rest of Europe Narcotic Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 103. Rest of Europe Narcotic Analgesics, by Dosage USD Million (2018-2023)
  • Table 104. MEA Narcotic Analgesics, by Country USD Million (2018-2023)
  • Table 105. MEA Narcotic Analgesics, by Type USD Million (2018-2023)
  • Table 106. MEA Narcotic Analgesics, by Form USD Million (2018-2023)
  • Table 107. MEA Narcotic Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 108. MEA Narcotic Analgesics, by Dosage USD Million (2018-2023)
  • Table 109. Middle East Narcotic Analgesics, by Type USD Million (2018-2023)
  • Table 110. Middle East Narcotic Analgesics, by Form USD Million (2018-2023)
  • Table 111. Middle East Narcotic Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 112. Middle East Narcotic Analgesics, by Dosage USD Million (2018-2023)
  • Table 113. Africa Narcotic Analgesics, by Type USD Million (2018-2023)
  • Table 114. Africa Narcotic Analgesics, by Form USD Million (2018-2023)
  • Table 115. Africa Narcotic Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 116. Africa Narcotic Analgesics, by Dosage USD Million (2018-2023)
  • Table 117. North America Narcotic Analgesics, by Country USD Million (2018-2023)
  • Table 118. North America Narcotic Analgesics, by Type USD Million (2018-2023)
  • Table 119. North America Narcotic Analgesics, by Form USD Million (2018-2023)
  • Table 120. North America Narcotic Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 121. North America Narcotic Analgesics, by Dosage USD Million (2018-2023)
  • Table 122. United States Narcotic Analgesics, by Type USD Million (2018-2023)
  • Table 123. United States Narcotic Analgesics, by Form USD Million (2018-2023)
  • Table 124. United States Narcotic Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 125. United States Narcotic Analgesics, by Dosage USD Million (2018-2023)
  • Table 126. Canada Narcotic Analgesics, by Type USD Million (2018-2023)
  • Table 127. Canada Narcotic Analgesics, by Form USD Million (2018-2023)
  • Table 128. Canada Narcotic Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 129. Canada Narcotic Analgesics, by Dosage USD Million (2018-2023)
  • Table 130. Mexico Narcotic Analgesics, by Type USD Million (2018-2023)
  • Table 131. Mexico Narcotic Analgesics, by Form USD Million (2018-2023)
  • Table 132. Mexico Narcotic Analgesics, by Distribution Channel USD Million (2018-2023)
  • Table 133. Mexico Narcotic Analgesics, by Dosage USD Million (2018-2023)
  • Table 134. Narcotic Analgesics Sales: by Type(K Units)
  • Table 135. Narcotic Analgesics Sales Oxycodone , by Region K Units (2018-2023)
  • Table 136. Narcotic Analgesics Sales Fentanyl , by Region K Units (2018-2023)
  • Table 137. Narcotic Analgesics Sales Hydrocodone , by Region K Units (2018-2023)
  • Table 138. Narcotic Analgesics Sales Hydromorphone , by Region K Units (2018-2023)
  • Table 139. Narcotic Analgesics Sales Morphine , by Region K Units (2018-2023)
  • Table 140. Narcotic Analgesics Sales Methadone , by Region K Units (2018-2023)
  • Table 141. Narcotic Analgesics Sales Oxymorphone , by Region K Units (2018-2023)
  • Table 142. Narcotic Analgesics Sales Pentazocine , by Region K Units (2018-2023)
  • Table 143. Narcotic Analgesics Sales: by Form(K Units)
  • Table 144. Narcotic Analgesics Sales Natural , by Region K Units (2018-2023)
  • Table 145. Narcotic Analgesics Sales Semi-Synthetic , by Region K Units (2018-2023)
  • Table 146. Narcotic Analgesics Sales Synthetic , by Region K Units (2018-2023)
  • Table 147. Narcotic Analgesics Sales: by Distribution Channel(K Units)
  • Table 148. Narcotic Analgesics Sales Hospital , by Region K Units (2018-2023)
  • Table 149. Narcotic Analgesics Sales Medical Center , by Region K Units (2018-2023)
  • Table 150. Narcotic Analgesics Sales Retail Pharmacies , by Region K Units (2018-2023)
  • Table 151. Narcotic Analgesics Sales Drug Stores , by Region K Units (2018-2023)
  • Table 152. Narcotic Analgesics Sales: by Dosage(K Units)
  • Table 153. Narcotic Analgesics Sales Tablets and Capsule , by Region K Units (2018-2023)
  • Table 154. Narcotic Analgesics Sales Patches , by Region K Units (2018-2023)
  • Table 155. Narcotic Analgesics Sales Injections , by Region K Units (2018-2023)
  • Table 156. Narcotic Analgesics Sales Oral Liquids , by Region K Units (2018-2023)
  • Table 157. Narcotic Analgesics Sales Others (Films, Sprays) , by Region K Units (2018-2023)
  • Table 158. South America Narcotic Analgesics Sales, by Country K Units (2018-2023)
  • Table 159. South America Narcotic Analgesics Sales, by Type K Units (2018-2023)
  • Table 160. South America Narcotic Analgesics Sales, by Form K Units (2018-2023)
  • Table 161. South America Narcotic Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 162. South America Narcotic Analgesics Sales, by Dosage K Units (2018-2023)
  • Table 163. Brazil Narcotic Analgesics Sales, by Type K Units (2018-2023)
  • Table 164. Brazil Narcotic Analgesics Sales, by Form K Units (2018-2023)
  • Table 165. Brazil Narcotic Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 166. Brazil Narcotic Analgesics Sales, by Dosage K Units (2018-2023)
  • Table 167. Argentina Narcotic Analgesics Sales, by Type K Units (2018-2023)
  • Table 168. Argentina Narcotic Analgesics Sales, by Form K Units (2018-2023)
  • Table 169. Argentina Narcotic Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 170. Argentina Narcotic Analgesics Sales, by Dosage K Units (2018-2023)
  • Table 171. Rest of South America Narcotic Analgesics Sales, by Type K Units (2018-2023)
  • Table 172. Rest of South America Narcotic Analgesics Sales, by Form K Units (2018-2023)
  • Table 173. Rest of South America Narcotic Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 174. Rest of South America Narcotic Analgesics Sales, by Dosage K Units (2018-2023)
  • Table 175. Asia Pacific Narcotic Analgesics Sales, by Country K Units (2018-2023)
  • Table 176. Asia Pacific Narcotic Analgesics Sales, by Type K Units (2018-2023)
  • Table 177. Asia Pacific Narcotic Analgesics Sales, by Form K Units (2018-2023)
  • Table 178. Asia Pacific Narcotic Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 179. Asia Pacific Narcotic Analgesics Sales, by Dosage K Units (2018-2023)
  • Table 180. China Narcotic Analgesics Sales, by Type K Units (2018-2023)
  • Table 181. China Narcotic Analgesics Sales, by Form K Units (2018-2023)
  • Table 182. China Narcotic Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 183. China Narcotic Analgesics Sales, by Dosage K Units (2018-2023)
  • Table 184. Japan Narcotic Analgesics Sales, by Type K Units (2018-2023)
  • Table 185. Japan Narcotic Analgesics Sales, by Form K Units (2018-2023)
  • Table 186. Japan Narcotic Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 187. Japan Narcotic Analgesics Sales, by Dosage K Units (2018-2023)
  • Table 188. India Narcotic Analgesics Sales, by Type K Units (2018-2023)
  • Table 189. India Narcotic Analgesics Sales, by Form K Units (2018-2023)
  • Table 190. India Narcotic Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 191. India Narcotic Analgesics Sales, by Dosage K Units (2018-2023)
  • Table 192. South Korea Narcotic Analgesics Sales, by Type K Units (2018-2023)
  • Table 193. South Korea Narcotic Analgesics Sales, by Form K Units (2018-2023)
  • Table 194. South Korea Narcotic Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 195. South Korea Narcotic Analgesics Sales, by Dosage K Units (2018-2023)
  • Table 196. Taiwan Narcotic Analgesics Sales, by Type K Units (2018-2023)
  • Table 197. Taiwan Narcotic Analgesics Sales, by Form K Units (2018-2023)
  • Table 198. Taiwan Narcotic Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 199. Taiwan Narcotic Analgesics Sales, by Dosage K Units (2018-2023)
  • Table 200. Australia Narcotic Analgesics Sales, by Type K Units (2018-2023)
  • Table 201. Australia Narcotic Analgesics Sales, by Form K Units (2018-2023)
  • Table 202. Australia Narcotic Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 203. Australia Narcotic Analgesics Sales, by Dosage K Units (2018-2023)
  • Table 204. Rest of Asia-Pacific Narcotic Analgesics Sales, by Type K Units (2018-2023)
  • Table 205. Rest of Asia-Pacific Narcotic Analgesics Sales, by Form K Units (2018-2023)
  • Table 206. Rest of Asia-Pacific Narcotic Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 207. Rest of Asia-Pacific Narcotic Analgesics Sales, by Dosage K Units (2018-2023)
  • Table 208. Europe Narcotic Analgesics Sales, by Country K Units (2018-2023)
  • Table 209. Europe Narcotic Analgesics Sales, by Type K Units (2018-2023)
  • Table 210. Europe Narcotic Analgesics Sales, by Form K Units (2018-2023)
  • Table 211. Europe Narcotic Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 212. Europe Narcotic Analgesics Sales, by Dosage K Units (2018-2023)
  • Table 213. Germany Narcotic Analgesics Sales, by Type K Units (2018-2023)
  • Table 214. Germany Narcotic Analgesics Sales, by Form K Units (2018-2023)
  • Table 215. Germany Narcotic Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 216. Germany Narcotic Analgesics Sales, by Dosage K Units (2018-2023)
  • Table 217. France Narcotic Analgesics Sales, by Type K Units (2018-2023)
  • Table 218. France Narcotic Analgesics Sales, by Form K Units (2018-2023)
  • Table 219. France Narcotic Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 220. France Narcotic Analgesics Sales, by Dosage K Units (2018-2023)
  • Table 221. Italy Narcotic Analgesics Sales, by Type K Units (2018-2023)
  • Table 222. Italy Narcotic Analgesics Sales, by Form K Units (2018-2023)
  • Table 223. Italy Narcotic Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 224. Italy Narcotic Analgesics Sales, by Dosage K Units (2018-2023)
  • Table 225. United Kingdom Narcotic Analgesics Sales, by Type K Units (2018-2023)
  • Table 226. United Kingdom Narcotic Analgesics Sales, by Form K Units (2018-2023)
  • Table 227. United Kingdom Narcotic Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 228. United Kingdom Narcotic Analgesics Sales, by Dosage K Units (2018-2023)
  • Table 229. Netherlands Narcotic Analgesics Sales, by Type K Units (2018-2023)
  • Table 230. Netherlands Narcotic Analgesics Sales, by Form K Units (2018-2023)
  • Table 231. Netherlands Narcotic Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 232. Netherlands Narcotic Analgesics Sales, by Dosage K Units (2018-2023)
  • Table 233. Rest of Europe Narcotic Analgesics Sales, by Type K Units (2018-2023)
  • Table 234. Rest of Europe Narcotic Analgesics Sales, by Form K Units (2018-2023)
  • Table 235. Rest of Europe Narcotic Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 236. Rest of Europe Narcotic Analgesics Sales, by Dosage K Units (2018-2023)
  • Table 237. MEA Narcotic Analgesics Sales, by Country K Units (2018-2023)
  • Table 238. MEA Narcotic Analgesics Sales, by Type K Units (2018-2023)
  • Table 239. MEA Narcotic Analgesics Sales, by Form K Units (2018-2023)
  • Table 240. MEA Narcotic Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 241. MEA Narcotic Analgesics Sales, by Dosage K Units (2018-2023)
  • Table 242. Middle East Narcotic Analgesics Sales, by Type K Units (2018-2023)
  • Table 243. Middle East Narcotic Analgesics Sales, by Form K Units (2018-2023)
  • Table 244. Middle East Narcotic Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 245. Middle East Narcotic Analgesics Sales, by Dosage K Units (2018-2023)
  • Table 246. Africa Narcotic Analgesics Sales, by Type K Units (2018-2023)
  • Table 247. Africa Narcotic Analgesics Sales, by Form K Units (2018-2023)
  • Table 248. Africa Narcotic Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 249. Africa Narcotic Analgesics Sales, by Dosage K Units (2018-2023)
  • Table 250. North America Narcotic Analgesics Sales, by Country K Units (2018-2023)
  • Table 251. North America Narcotic Analgesics Sales, by Type K Units (2018-2023)
  • Table 252. North America Narcotic Analgesics Sales, by Form K Units (2018-2023)
  • Table 253. North America Narcotic Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 254. North America Narcotic Analgesics Sales, by Dosage K Units (2018-2023)
  • Table 255. United States Narcotic Analgesics Sales, by Type K Units (2018-2023)
  • Table 256. United States Narcotic Analgesics Sales, by Form K Units (2018-2023)
  • Table 257. United States Narcotic Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 258. United States Narcotic Analgesics Sales, by Dosage K Units (2018-2023)
  • Table 259. Canada Narcotic Analgesics Sales, by Type K Units (2018-2023)
  • Table 260. Canada Narcotic Analgesics Sales, by Form K Units (2018-2023)
  • Table 261. Canada Narcotic Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 262. Canada Narcotic Analgesics Sales, by Dosage K Units (2018-2023)
  • Table 263. Mexico Narcotic Analgesics Sales, by Type K Units (2018-2023)
  • Table 264. Mexico Narcotic Analgesics Sales, by Form K Units (2018-2023)
  • Table 265. Mexico Narcotic Analgesics Sales, by Distribution Channel K Units (2018-2023)
  • Table 266. Mexico Narcotic Analgesics Sales, by Dosage K Units (2018-2023)
  • Table 267. Narcotic Analgesics: by Type(USD/Units)
  • Table 268. Company Basic Information, Sales Area and Its Competitors
  • Table 269. Company Basic Information, Sales Area and Its Competitors
  • Table 270. Company Basic Information, Sales Area and Its Competitors
  • Table 271. Company Basic Information, Sales Area and Its Competitors
  • Table 272. Company Basic Information, Sales Area and Its Competitors
  • Table 273. Company Basic Information, Sales Area and Its Competitors
  • Table 274. Company Basic Information, Sales Area and Its Competitors
  • Table 275. Company Basic Information, Sales Area and Its Competitors
  • Table 276. Narcotic Analgesics: by Type(USD Million)
  • Table 277. Narcotic Analgesics Oxycodone , by Region USD Million (2025-2030)
  • Table 278. Narcotic Analgesics Fentanyl , by Region USD Million (2025-2030)
  • Table 279. Narcotic Analgesics Hydrocodone , by Region USD Million (2025-2030)
  • Table 280. Narcotic Analgesics Hydromorphone , by Region USD Million (2025-2030)
  • Table 281. Narcotic Analgesics Morphine , by Region USD Million (2025-2030)
  • Table 282. Narcotic Analgesics Methadone , by Region USD Million (2025-2030)
  • Table 283. Narcotic Analgesics Oxymorphone , by Region USD Million (2025-2030)
  • Table 284. Narcotic Analgesics Pentazocine , by Region USD Million (2025-2030)
  • Table 285. Narcotic Analgesics: by Form(USD Million)
  • Table 286. Narcotic Analgesics Natural , by Region USD Million (2025-2030)
  • Table 287. Narcotic Analgesics Semi-Synthetic , by Region USD Million (2025-2030)
  • Table 288. Narcotic Analgesics Synthetic , by Region USD Million (2025-2030)
  • Table 289. Narcotic Analgesics: by Distribution Channel(USD Million)
  • Table 290. Narcotic Analgesics Hospital , by Region USD Million (2025-2030)
  • Table 291. Narcotic Analgesics Medical Center , by Region USD Million (2025-2030)
  • Table 292. Narcotic Analgesics Retail Pharmacies , by Region USD Million (2025-2030)
  • Table 293. Narcotic Analgesics Drug Stores , by Region USD Million (2025-2030)
  • Table 294. Narcotic Analgesics: by Dosage(USD Million)
  • Table 295. Narcotic Analgesics Tablets and Capsule , by Region USD Million (2025-2030)
  • Table 296. Narcotic Analgesics Patches , by Region USD Million (2025-2030)
  • Table 297. Narcotic Analgesics Injections , by Region USD Million (2025-2030)
  • Table 298. Narcotic Analgesics Oral Liquids , by Region USD Million (2025-2030)
  • Table 299. Narcotic Analgesics Others (Films, Sprays) , by Region USD Million (2025-2030)
  • Table 300. South America Narcotic Analgesics, by Country USD Million (2025-2030)
  • Table 301. South America Narcotic Analgesics, by Type USD Million (2025-2030)
  • Table 302. South America Narcotic Analgesics, by Form USD Million (2025-2030)
  • Table 303. South America Narcotic Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 304. South America Narcotic Analgesics, by Dosage USD Million (2025-2030)
  • Table 305. Brazil Narcotic Analgesics, by Type USD Million (2025-2030)
  • Table 306. Brazil Narcotic Analgesics, by Form USD Million (2025-2030)
  • Table 307. Brazil Narcotic Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 308. Brazil Narcotic Analgesics, by Dosage USD Million (2025-2030)
  • Table 309. Argentina Narcotic Analgesics, by Type USD Million (2025-2030)
  • Table 310. Argentina Narcotic Analgesics, by Form USD Million (2025-2030)
  • Table 311. Argentina Narcotic Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 312. Argentina Narcotic Analgesics, by Dosage USD Million (2025-2030)
  • Table 313. Rest of South America Narcotic Analgesics, by Type USD Million (2025-2030)
  • Table 314. Rest of South America Narcotic Analgesics, by Form USD Million (2025-2030)
  • Table 315. Rest of South America Narcotic Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 316. Rest of South America Narcotic Analgesics, by Dosage USD Million (2025-2030)
  • Table 317. Asia Pacific Narcotic Analgesics, by Country USD Million (2025-2030)
  • Table 318. Asia Pacific Narcotic Analgesics, by Type USD Million (2025-2030)
  • Table 319. Asia Pacific Narcotic Analgesics, by Form USD Million (2025-2030)
  • Table 320. Asia Pacific Narcotic Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 321. Asia Pacific Narcotic Analgesics, by Dosage USD Million (2025-2030)
  • Table 322. China Narcotic Analgesics, by Type USD Million (2025-2030)
  • Table 323. China Narcotic Analgesics, by Form USD Million (2025-2030)
  • Table 324. China Narcotic Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 325. China Narcotic Analgesics, by Dosage USD Million (2025-2030)
  • Table 326. Japan Narcotic Analgesics, by Type USD Million (2025-2030)
  • Table 327. Japan Narcotic Analgesics, by Form USD Million (2025-2030)
  • Table 328. Japan Narcotic Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 329. Japan Narcotic Analgesics, by Dosage USD Million (2025-2030)
  • Table 330. India Narcotic Analgesics, by Type USD Million (2025-2030)
  • Table 331. India Narcotic Analgesics, by Form USD Million (2025-2030)
  • Table 332. India Narcotic Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 333. India Narcotic Analgesics, by Dosage USD Million (2025-2030)
  • Table 334. South Korea Narcotic Analgesics, by Type USD Million (2025-2030)
  • Table 335. South Korea Narcotic Analgesics, by Form USD Million (2025-2030)
  • Table 336. South Korea Narcotic Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 337. South Korea Narcotic Analgesics, by Dosage USD Million (2025-2030)
  • Table 338. Taiwan Narcotic Analgesics, by Type USD Million (2025-2030)
  • Table 339. Taiwan Narcotic Analgesics, by Form USD Million (2025-2030)
  • Table 340. Taiwan Narcotic Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 341. Taiwan Narcotic Analgesics, by Dosage USD Million (2025-2030)
  • Table 342. Australia Narcotic Analgesics, by Type USD Million (2025-2030)
  • Table 343. Australia Narcotic Analgesics, by Form USD Million (2025-2030)
  • Table 344. Australia Narcotic Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 345. Australia Narcotic Analgesics, by Dosage USD Million (2025-2030)
  • Table 346. Rest of Asia-Pacific Narcotic Analgesics, by Type USD Million (2025-2030)
  • Table 347. Rest of Asia-Pacific Narcotic Analgesics, by Form USD Million (2025-2030)
  • Table 348. Rest of Asia-Pacific Narcotic Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 349. Rest of Asia-Pacific Narcotic Analgesics, by Dosage USD Million (2025-2030)
  • Table 350. Europe Narcotic Analgesics, by Country USD Million (2025-2030)
  • Table 351. Europe Narcotic Analgesics, by Type USD Million (2025-2030)
  • Table 352. Europe Narcotic Analgesics, by Form USD Million (2025-2030)
  • Table 353. Europe Narcotic Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 354. Europe Narcotic Analgesics, by Dosage USD Million (2025-2030)
  • Table 355. Germany Narcotic Analgesics, by Type USD Million (2025-2030)
  • Table 356. Germany Narcotic Analgesics, by Form USD Million (2025-2030)
  • Table 357. Germany Narcotic Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 358. Germany Narcotic Analgesics, by Dosage USD Million (2025-2030)
  • Table 359. France Narcotic Analgesics, by Type USD Million (2025-2030)
  • Table 360. France Narcotic Analgesics, by Form USD Million (2025-2030)
  • Table 361. France Narcotic Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 362. France Narcotic Analgesics, by Dosage USD Million (2025-2030)
  • Table 363. Italy Narcotic Analgesics, by Type USD Million (2025-2030)
  • Table 364. Italy Narcotic Analgesics, by Form USD Million (2025-2030)
  • Table 365. Italy Narcotic Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 366. Italy Narcotic Analgesics, by Dosage USD Million (2025-2030)
  • Table 367. United Kingdom Narcotic Analgesics, by Type USD Million (2025-2030)
  • Table 368. United Kingdom Narcotic Analgesics, by Form USD Million (2025-2030)
  • Table 369. United Kingdom Narcotic Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 370. United Kingdom Narcotic Analgesics, by Dosage USD Million (2025-2030)
  • Table 371. Netherlands Narcotic Analgesics, by Type USD Million (2025-2030)
  • Table 372. Netherlands Narcotic Analgesics, by Form USD Million (2025-2030)
  • Table 373. Netherlands Narcotic Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 374. Netherlands Narcotic Analgesics, by Dosage USD Million (2025-2030)
  • Table 375. Rest of Europe Narcotic Analgesics, by Type USD Million (2025-2030)
  • Table 376. Rest of Europe Narcotic Analgesics, by Form USD Million (2025-2030)
  • Table 377. Rest of Europe Narcotic Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 378. Rest of Europe Narcotic Analgesics, by Dosage USD Million (2025-2030)
  • Table 379. MEA Narcotic Analgesics, by Country USD Million (2025-2030)
  • Table 380. MEA Narcotic Analgesics, by Type USD Million (2025-2030)
  • Table 381. MEA Narcotic Analgesics, by Form USD Million (2025-2030)
  • Table 382. MEA Narcotic Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 383. MEA Narcotic Analgesics, by Dosage USD Million (2025-2030)
  • Table 384. Middle East Narcotic Analgesics, by Type USD Million (2025-2030)
  • Table 385. Middle East Narcotic Analgesics, by Form USD Million (2025-2030)
  • Table 386. Middle East Narcotic Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 387. Middle East Narcotic Analgesics, by Dosage USD Million (2025-2030)
  • Table 388. Africa Narcotic Analgesics, by Type USD Million (2025-2030)
  • Table 389. Africa Narcotic Analgesics, by Form USD Million (2025-2030)
  • Table 390. Africa Narcotic Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 391. Africa Narcotic Analgesics, by Dosage USD Million (2025-2030)
  • Table 392. North America Narcotic Analgesics, by Country USD Million (2025-2030)
  • Table 393. North America Narcotic Analgesics, by Type USD Million (2025-2030)
  • Table 394. North America Narcotic Analgesics, by Form USD Million (2025-2030)
  • Table 395. North America Narcotic Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 396. North America Narcotic Analgesics, by Dosage USD Million (2025-2030)
  • Table 397. United States Narcotic Analgesics, by Type USD Million (2025-2030)
  • Table 398. United States Narcotic Analgesics, by Form USD Million (2025-2030)
  • Table 399. United States Narcotic Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 400. United States Narcotic Analgesics, by Dosage USD Million (2025-2030)
  • Table 401. Canada Narcotic Analgesics, by Type USD Million (2025-2030)
  • Table 402. Canada Narcotic Analgesics, by Form USD Million (2025-2030)
  • Table 403. Canada Narcotic Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 404. Canada Narcotic Analgesics, by Dosage USD Million (2025-2030)
  • Table 405. Mexico Narcotic Analgesics, by Type USD Million (2025-2030)
  • Table 406. Mexico Narcotic Analgesics, by Form USD Million (2025-2030)
  • Table 407. Mexico Narcotic Analgesics, by Distribution Channel USD Million (2025-2030)
  • Table 408. Mexico Narcotic Analgesics, by Dosage USD Million (2025-2030)
  • Table 409. Narcotic Analgesics Sales: by Type(K Units)
  • Table 410. Narcotic Analgesics Sales Oxycodone , by Region K Units (2025-2030)
  • Table 411. Narcotic Analgesics Sales Fentanyl , by Region K Units (2025-2030)
  • Table 412. Narcotic Analgesics Sales Hydrocodone , by Region K Units (2025-2030)
  • Table 413. Narcotic Analgesics Sales Hydromorphone , by Region K Units (2025-2030)
  • Table 414. Narcotic Analgesics Sales Morphine , by Region K Units (2025-2030)
  • Table 415. Narcotic Analgesics Sales Methadone , by Region K Units (2025-2030)
  • Table 416. Narcotic Analgesics Sales Oxymorphone , by Region K Units (2025-2030)
  • Table 417. Narcotic Analgesics Sales Pentazocine , by Region K Units (2025-2030)
  • Table 418. Narcotic Analgesics Sales: by Form(K Units)
  • Table 419. Narcotic Analgesics Sales Natural , by Region K Units (2025-2030)
  • Table 420. Narcotic Analgesics Sales Semi-Synthetic , by Region K Units (2025-2030)
  • Table 421. Narcotic Analgesics Sales Synthetic , by Region K Units (2025-2030)
  • Table 422. Narcotic Analgesics Sales: by Distribution Channel(K Units)
  • Table 423. Narcotic Analgesics Sales Hospital , by Region K Units (2025-2030)
  • Table 424. Narcotic Analgesics Sales Medical Center , by Region K Units (2025-2030)
  • Table 425. Narcotic Analgesics Sales Retail Pharmacies , by Region K Units (2025-2030)
  • Table 426. Narcotic Analgesics Sales Drug Stores , by Region K Units (2025-2030)
  • Table 427. Narcotic Analgesics Sales: by Dosage(K Units)
  • Table 428. Narcotic Analgesics Sales Tablets and Capsule , by Region K Units (2025-2030)
  • Table 429. Narcotic Analgesics Sales Patches , by Region K Units (2025-2030)
  • Table 430. Narcotic Analgesics Sales Injections , by Region K Units (2025-2030)
  • Table 431. Narcotic Analgesics Sales Oral Liquids , by Region K Units (2025-2030)
  • Table 432. Narcotic Analgesics Sales Others (Films, Sprays) , by Region K Units (2025-2030)
  • Table 433. South America Narcotic Analgesics Sales, by Country K Units (2025-2030)
  • Table 434. South America Narcotic Analgesics Sales, by Type K Units (2025-2030)
  • Table 435. South America Narcotic Analgesics Sales, by Form K Units (2025-2030)
  • Table 436. South America Narcotic Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 437. South America Narcotic Analgesics Sales, by Dosage K Units (2025-2030)
  • Table 438. Brazil Narcotic Analgesics Sales, by Type K Units (2025-2030)
  • Table 439. Brazil Narcotic Analgesics Sales, by Form K Units (2025-2030)
  • Table 440. Brazil Narcotic Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 441. Brazil Narcotic Analgesics Sales, by Dosage K Units (2025-2030)
  • Table 442. Argentina Narcotic Analgesics Sales, by Type K Units (2025-2030)
  • Table 443. Argentina Narcotic Analgesics Sales, by Form K Units (2025-2030)
  • Table 444. Argentina Narcotic Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 445. Argentina Narcotic Analgesics Sales, by Dosage K Units (2025-2030)
  • Table 446. Rest of South America Narcotic Analgesics Sales, by Type K Units (2025-2030)
  • Table 447. Rest of South America Narcotic Analgesics Sales, by Form K Units (2025-2030)
  • Table 448. Rest of South America Narcotic Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 449. Rest of South America Narcotic Analgesics Sales, by Dosage K Units (2025-2030)
  • Table 450. Asia Pacific Narcotic Analgesics Sales, by Country K Units (2025-2030)
  • Table 451. Asia Pacific Narcotic Analgesics Sales, by Type K Units (2025-2030)
  • Table 452. Asia Pacific Narcotic Analgesics Sales, by Form K Units (2025-2030)
  • Table 453. Asia Pacific Narcotic Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 454. Asia Pacific Narcotic Analgesics Sales, by Dosage K Units (2025-2030)
  • Table 455. China Narcotic Analgesics Sales, by Type K Units (2025-2030)
  • Table 456. China Narcotic Analgesics Sales, by Form K Units (2025-2030)
  • Table 457. China Narcotic Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 458. China Narcotic Analgesics Sales, by Dosage K Units (2025-2030)
  • Table 459. Japan Narcotic Analgesics Sales, by Type K Units (2025-2030)
  • Table 460. Japan Narcotic Analgesics Sales, by Form K Units (2025-2030)
  • Table 461. Japan Narcotic Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 462. Japan Narcotic Analgesics Sales, by Dosage K Units (2025-2030)
  • Table 463. India Narcotic Analgesics Sales, by Type K Units (2025-2030)
  • Table 464. India Narcotic Analgesics Sales, by Form K Units (2025-2030)
  • Table 465. India Narcotic Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 466. India Narcotic Analgesics Sales, by Dosage K Units (2025-2030)
  • Table 467. South Korea Narcotic Analgesics Sales, by Type K Units (2025-2030)
  • Table 468. South Korea Narcotic Analgesics Sales, by Form K Units (2025-2030)
  • Table 469. South Korea Narcotic Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 470. South Korea Narcotic Analgesics Sales, by Dosage K Units (2025-2030)
  • Table 471. Taiwan Narcotic Analgesics Sales, by Type K Units (2025-2030)
  • Table 472. Taiwan Narcotic Analgesics Sales, by Form K Units (2025-2030)
  • Table 473. Taiwan Narcotic Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 474. Taiwan Narcotic Analgesics Sales, by Dosage K Units (2025-2030)
  • Table 475. Australia Narcotic Analgesics Sales, by Type K Units (2025-2030)
  • Table 476. Australia Narcotic Analgesics Sales, by Form K Units (2025-2030)
  • Table 477. Australia Narcotic Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 478. Australia Narcotic Analgesics Sales, by Dosage K Units (2025-2030)
  • Table 479. Rest of Asia-Pacific Narcotic Analgesics Sales, by Type K Units (2025-2030)
  • Table 480. Rest of Asia-Pacific Narcotic Analgesics Sales, by Form K Units (2025-2030)
  • Table 481. Rest of Asia-Pacific Narcotic Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 482. Rest of Asia-Pacific Narcotic Analgesics Sales, by Dosage K Units (2025-2030)
  • Table 483. Europe Narcotic Analgesics Sales, by Country K Units (2025-2030)
  • Table 484. Europe Narcotic Analgesics Sales, by Type K Units (2025-2030)
  • Table 485. Europe Narcotic Analgesics Sales, by Form K Units (2025-2030)
  • Table 486. Europe Narcotic Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 487. Europe Narcotic Analgesics Sales, by Dosage K Units (2025-2030)
  • Table 488. Germany Narcotic Analgesics Sales, by Type K Units (2025-2030)
  • Table 489. Germany Narcotic Analgesics Sales, by Form K Units (2025-2030)
  • Table 490. Germany Narcotic Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 491. Germany Narcotic Analgesics Sales, by Dosage K Units (2025-2030)
  • Table 492. France Narcotic Analgesics Sales, by Type K Units (2025-2030)
  • Table 493. France Narcotic Analgesics Sales, by Form K Units (2025-2030)
  • Table 494. France Narcotic Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 495. France Narcotic Analgesics Sales, by Dosage K Units (2025-2030)
  • Table 496. Italy Narcotic Analgesics Sales, by Type K Units (2025-2030)
  • Table 497. Italy Narcotic Analgesics Sales, by Form K Units (2025-2030)
  • Table 498. Italy Narcotic Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 499. Italy Narcotic Analgesics Sales, by Dosage K Units (2025-2030)
  • Table 500. United Kingdom Narcotic Analgesics Sales, by Type K Units (2025-2030)
  • Table 501. United Kingdom Narcotic Analgesics Sales, by Form K Units (2025-2030)
  • Table 502. United Kingdom Narcotic Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 503. United Kingdom Narcotic Analgesics Sales, by Dosage K Units (2025-2030)
  • Table 504. Netherlands Narcotic Analgesics Sales, by Type K Units (2025-2030)
  • Table 505. Netherlands Narcotic Analgesics Sales, by Form K Units (2025-2030)
  • Table 506. Netherlands Narcotic Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 507. Netherlands Narcotic Analgesics Sales, by Dosage K Units (2025-2030)
  • Table 508. Rest of Europe Narcotic Analgesics Sales, by Type K Units (2025-2030)
  • Table 509. Rest of Europe Narcotic Analgesics Sales, by Form K Units (2025-2030)
  • Table 510. Rest of Europe Narcotic Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 511. Rest of Europe Narcotic Analgesics Sales, by Dosage K Units (2025-2030)
  • Table 512. MEA Narcotic Analgesics Sales, by Country K Units (2025-2030)
  • Table 513. MEA Narcotic Analgesics Sales, by Type K Units (2025-2030)
  • Table 514. MEA Narcotic Analgesics Sales, by Form K Units (2025-2030)
  • Table 515. MEA Narcotic Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 516. MEA Narcotic Analgesics Sales, by Dosage K Units (2025-2030)
  • Table 517. Middle East Narcotic Analgesics Sales, by Type K Units (2025-2030)
  • Table 518. Middle East Narcotic Analgesics Sales, by Form K Units (2025-2030)
  • Table 519. Middle East Narcotic Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 520. Middle East Narcotic Analgesics Sales, by Dosage K Units (2025-2030)
  • Table 521. Africa Narcotic Analgesics Sales, by Type K Units (2025-2030)
  • Table 522. Africa Narcotic Analgesics Sales, by Form K Units (2025-2030)
  • Table 523. Africa Narcotic Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 524. Africa Narcotic Analgesics Sales, by Dosage K Units (2025-2030)
  • Table 525. North America Narcotic Analgesics Sales, by Country K Units (2025-2030)
  • Table 526. North America Narcotic Analgesics Sales, by Type K Units (2025-2030)
  • Table 527. North America Narcotic Analgesics Sales, by Form K Units (2025-2030)
  • Table 528. North America Narcotic Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 529. North America Narcotic Analgesics Sales, by Dosage K Units (2025-2030)
  • Table 530. United States Narcotic Analgesics Sales, by Type K Units (2025-2030)
  • Table 531. United States Narcotic Analgesics Sales, by Form K Units (2025-2030)
  • Table 532. United States Narcotic Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 533. United States Narcotic Analgesics Sales, by Dosage K Units (2025-2030)
  • Table 534. Canada Narcotic Analgesics Sales, by Type K Units (2025-2030)
  • Table 535. Canada Narcotic Analgesics Sales, by Form K Units (2025-2030)
  • Table 536. Canada Narcotic Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 537. Canada Narcotic Analgesics Sales, by Dosage K Units (2025-2030)
  • Table 538. Mexico Narcotic Analgesics Sales, by Type K Units (2025-2030)
  • Table 539. Mexico Narcotic Analgesics Sales, by Form K Units (2025-2030)
  • Table 540. Mexico Narcotic Analgesics Sales, by Distribution Channel K Units (2025-2030)
  • Table 541. Mexico Narcotic Analgesics Sales, by Dosage K Units (2025-2030)
  • Table 542. Narcotic Analgesics: by Type(USD/Units)
  • Table 543. Research Programs/Design for This Report
  • Table 544. Key Data Information from Secondary Sources
  • Table 545. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Narcotic Analgesics: by Type USD Million (2018-2023)
  • Figure 5. Global Narcotic Analgesics: by Form USD Million (2018-2023)
  • Figure 6. Global Narcotic Analgesics: by Distribution Channel USD Million (2018-2023)
  • Figure 7. Global Narcotic Analgesics: by Dosage USD Million (2018-2023)
  • Figure 8. South America Narcotic Analgesics Share (%), by Country
  • Figure 9. Asia Pacific Narcotic Analgesics Share (%), by Country
  • Figure 10. Europe Narcotic Analgesics Share (%), by Country
  • Figure 11. MEA Narcotic Analgesics Share (%), by Country
  • Figure 12. North America Narcotic Analgesics Share (%), by Country
  • Figure 13. Global Narcotic Analgesics: by Type K Units (2018-2023)
  • Figure 14. Global Narcotic Analgesics: by Form K Units (2018-2023)
  • Figure 15. Global Narcotic Analgesics: by Distribution Channel K Units (2018-2023)
  • Figure 16. Global Narcotic Analgesics: by Dosage K Units (2018-2023)
  • Figure 17. South America Narcotic Analgesics Share (%), by Country
  • Figure 18. Asia Pacific Narcotic Analgesics Share (%), by Country
  • Figure 19. Europe Narcotic Analgesics Share (%), by Country
  • Figure 20. MEA Narcotic Analgesics Share (%), by Country
  • Figure 21. North America Narcotic Analgesics Share (%), by Country
  • Figure 22. Global Narcotic Analgesics: by Type USD/Units (2018-2023)
  • Figure 23. Global Narcotic Analgesics share by Players 2023 (%)
  • Figure 24. Global Narcotic Analgesics share by Players (Top 3) 2023(%)
  • Figure 25. Global Narcotic Analgesics share by Players (Top 5) 2023(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Sanofi S.A. (France) Revenue, Net Income and Gross profit
  • Figure 28. Sanofi S.A. (France) Revenue: by Geography 2023
  • Figure 29. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 30. Novartis AG (Switzerland) Revenue: by Geography 2023
  • Figure 31. GlaxoSmithKline PLC (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. GlaxoSmithKline PLC (United Kingdom) Revenue: by Geography 2023
  • Figure 33. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 34. Pfizer (United States) Revenue: by Geography 2023
  • Figure 35. Reckitt Benckiser (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 36. Reckitt Benckiser (United Kingdom) Revenue: by Geography 2023
  • Figure 37. Endo Pharmaceuticals (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 38. Endo Pharmaceuticals (United Kingdom) Revenue: by Geography 2023
  • Figure 39. Mallinckrodt Pharmaceuticals (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 40. Mallinckrodt Pharmaceuticals (United Kingdom) Revenue: by Geography 2023
  • Figure 41. Endo Pharmaceuticals Inc. (Ireland) Revenue, Net Income and Gross profit
  • Figure 42. Endo Pharmaceuticals Inc. (Ireland) Revenue: by Geography 2023
  • Figure 43. Global Narcotic Analgesics: by Type USD Million (2025-2030)
  • Figure 44. Global Narcotic Analgesics: by Form USD Million (2025-2030)
  • Figure 45. Global Narcotic Analgesics: by Distribution Channel USD Million (2025-2030)
  • Figure 46. Global Narcotic Analgesics: by Dosage USD Million (2025-2030)
  • Figure 47. South America Narcotic Analgesics Share (%), by Country
  • Figure 48. Asia Pacific Narcotic Analgesics Share (%), by Country
  • Figure 49. Europe Narcotic Analgesics Share (%), by Country
  • Figure 50. MEA Narcotic Analgesics Share (%), by Country
  • Figure 51. North America Narcotic Analgesics Share (%), by Country
  • Figure 52. Global Narcotic Analgesics: by Type K Units (2025-2030)
  • Figure 53. Global Narcotic Analgesics: by Form K Units (2025-2030)
  • Figure 54. Global Narcotic Analgesics: by Distribution Channel K Units (2025-2030)
  • Figure 55. Global Narcotic Analgesics: by Dosage K Units (2025-2030)
  • Figure 56. South America Narcotic Analgesics Share (%), by Country
  • Figure 57. Asia Pacific Narcotic Analgesics Share (%), by Country
  • Figure 58. Europe Narcotic Analgesics Share (%), by Country
  • Figure 59. MEA Narcotic Analgesics Share (%), by Country
  • Figure 60. North America Narcotic Analgesics Share (%), by Country
  • Figure 61. Global Narcotic Analgesics: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Sanofi S.A. (France)
  • Novartis AG (Switzerland)
  • GlaxoSmithKline PLC (United Kingdom)
  • Pfizer (United States)
  • Reckitt Benckiser (United Kingdom)
  • Endo Pharmaceuticals (United Kingdom)
  • Mallinckrodt Pharmaceuticals (United Kingdom)
  • Endo Pharmaceuticals Inc. (Ireland)
Additional players considered in the study are as follows:
Sun Pharmaceutical Industries Ltd. (India) , Egalet (United States)
Select User Access Type

Key Highlights of Report


Apr 2024 166 Pages 97 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Narcotic Analgesics Market Quantitative research analysis
Global Narcotic Analgesics Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Narcotic Analgesics Market are by type [Oxycodone, Fentanyl, Hydrocodone, Hydromorphone, Morphine, Methadone, Oxymorphone and Pentazocine], by end use application [].
The Narcotic Analgesics Market is gaining popularity and expected to see strong valuation by 2030.
  • High Growth of Tolerance for Non-Narcotic Analgesics
  • High Demand for High Pain Management
  • Increasing Number Chronic Pain Associated With Cancer and Arthritis Conditions

Know More About Global Narcotic Analgesics Market Report?

Have a Query? Click Here

Other Related Reports

Topical Analgesics Comprehensive Study by Type (Prescription Pain Relief, Over-The-Counter Pain Relief), Distribution Channel (Pharmacies & Drug Stores, E-Commerce, Retail & Grocery Stores), Formulat...
$ 3450
Functional Powder Drinks Comprehensive Study by Type (Organic, Conventional), Distribution Channel (Online Stores, Hypermarket/Supermarket, Offline Retail Stores, Other Convenience Stores), Ingredien...
$ 3650
Open Heel Nursing Clogs Comprehensive Study by Type (Wooden Upper Clog, Wooden Soled Clog, Others), Application (Hospitals, Clinics, Ambulatory Surgical Centers), Distribution Channel (Online, Offlin...
$ 3450
Pharmaceuticals Pouch Comprehensive Study by Type (Tamper Evident Pouches, High Barrier / Chemical Resistant Pouches, Breathable Pouches, Non-Peelable Pouches, Peelable Pouch), Application (Pharmaceu...
$ 3750
Eye Health Ingredients Comprehensive Study by Type (Lutein, Zeaxanthin, Vitamin A, Beta-carotene, Bilberry extracts, Other), Application (Pharmaceuticals, Supplements, Beverages, Oils and Fats, Baker...
$ 3650
Wearable Patch Comprehensive Study by Type (Temperature Patch, Blood Glucose Patch, Blood Pressure/Flow Patch, Heart Rate Patch, ECG Patch, Blood Oxygen Patch, Others (Position Sensor, Sweat Analyzer...
$ 3750